Physician profile
Michael A Lee
NPI 1124020193
$1,356.49
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $148 · 2021: $654 · 2022: $258.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $178.22 | 2021-2022 | |
| Lilly USA, LLC | $152.74 | 2021-2022 | |
| Novo Nordisk INC | $150.28 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $148.76 | 2021-2022 | |
| Astellas Pharma US INC | $95.62 | 2019-2022 | |
| Amgen INC. | $89.21 | 2019-2022 | |
| Eisai INC. | $60.44 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.13 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.64 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $54.52 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $38.40 | 2020-2021 | |
| Glaxosmithkline, LLC. | $37.55 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $37.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.01 | 2021 | |
| Pfizer INC. | $33.70 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $30.46 | 2021 | |
| Allergan, INC. | $28.05 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $17.90 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $16.47 | 2021 | |
| Medtronic, INC. | $12.32 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.14 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $11.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.